PT72502A - Androstane carbothioates - Google Patents

Androstane carbothioates

Info

Publication number
PT72502A
PT72502A PT72502A PT7250281A PT72502A PT 72502 A PT72502 A PT 72502A PT 72502 A PT72502 A PT 72502A PT 7250281 A PT7250281 A PT 7250281A PT 72502 A PT72502 A PT 72502A
Authority
PT
Portugal
Prior art keywords
group
alpha
compounds
hydrogen
formula
Prior art date
Application number
PT72502A
Other languages
Portuguese (pt)
Other versions
PT72502B (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PT72502A publication Critical patent/PT72502A/en
Publication of PT72502B publication Critical patent/PT72502B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of the formula <IMAGE> in which R<1> is a fluoro-, chloro- or bromomethyl group or a 2'-fluoroethyl group, R<2> is a group COR<6> in which R<6> is a C1-3-alkyl group, or OR<2> and R<3> together form a 16 alpha ,17 alpha -isopropylidenedioxy group; R<3> is a hydrogen atom, a methyl group (which can be present in either the alpha or the ss configuration) or a methylene group; R<4> is a hydrogen, chlorine or fluorine atom; R<5> is a hydrogen or fluorine atom, and the symbol ..... is a single or double bond. The compounds have good anti-inflammatory activity, in particular on topical application. The compounds of the formula I are prepared by esterification, halogenation, reduction, elimination of protective groups and reaction at a 9,11 double bond to form a 9 alpha -halo-11ss-hydroxy group.
PT72502A 1980-02-15 1981-02-13 Androstane carbothioates PT72502B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8005174 1980-02-15
GB8013339 1980-04-23

Publications (2)

Publication Number Publication Date
PT72502A true PT72502A (en) 1981-03-01
PT72502B PT72502B (en) 1982-02-05

Family

ID=26274505

Family Applications (1)

Application Number Title Priority Date Filing Date
PT72502A PT72502B (en) 1980-02-15 1981-02-13 Androstane carbothioates

Country Status (23)

Country Link
KR (1) KR850000969B1 (en)
AT (1) AT395427B (en)
AU (1) AU544517B2 (en)
BG (1) BG60700B2 (en)
CH (2) CH644615A5 (en)
CZ (1) CZ281275B6 (en)
DE (2) DE3105307A1 (en)
DK (1) DK147022C (en)
ES (5) ES499394A0 (en)
FI (1) FI70904C (en)
FR (2) FR2477156A1 (en)
HK (1) HK58385A (en)
IE (1) IE51394B1 (en)
IT (1) IT1170717B (en)
KE (1) KE3526A (en)
MX (1) MX9202717A (en)
MY (1) MY8500757A (en)
NL (2) NL191792C (en)
NZ (1) NZ196260A (en)
PT (1) PT72502B (en)
SE (1) SE452468B (en)
SG (1) SG36885G (en)
SK (1) SK403491A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA817929B (en) * 1980-12-22 1982-10-27 Upjohn Co 5alpha-and 5beta-androstane-17beta-carboxylates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436549A (en) * 1972-06-15 1976-05-19 Glaxo Lab Ltd 17beta-mercaptocarbonyl-3alpha-hydroxy-steroids and their esters
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
GB1580517A (en) * 1978-04-06 1980-12-03 Fowler I Crutches

Also Published As

Publication number Publication date
ES8502447A1 (en) 1985-01-01
FI70904B (en) 1986-07-18
DE3153379C2 (en) 1992-11-19
ES532055A0 (en) 1985-10-16
ES524985A0 (en) 1985-01-01
SK278140B6 (en) 1996-02-07
HK58385A (en) 1985-08-16
ES8402317A1 (en) 1984-01-16
AT395427B (en) 1992-12-28
FR2485542B1 (en) 1983-06-10
ES8207194A1 (en) 1982-09-01
ES8305379A1 (en) 1983-04-01
MX9202717A (en) 1992-06-30
FI70904C (en) 1986-10-27
PT72502B (en) 1982-02-05
DK62381A (en) 1981-08-16
AU544517B2 (en) 1985-06-06
ATA67481A (en) 1992-05-15
BG60700B2 (en) 1995-12-29
SE8101010L (en) 1981-08-16
CH651307A5 (en) 1985-09-13
FR2477156B1 (en) 1984-11-16
DE3105307C2 (en) 1988-09-29
SE452468B (en) 1987-11-30
KR850000969B1 (en) 1985-07-02
FR2485542A1 (en) 1981-12-31
CH644615A5 (en) 1984-08-15
FR2477156A1 (en) 1981-09-04
SG36885G (en) 1985-11-15
KR830005262A (en) 1983-08-03
NL8100707A (en) 1981-09-16
ES518161A0 (en) 1984-01-16
NZ196260A (en) 1983-11-30
KE3526A (en) 1985-06-07
ES8600936A1 (en) 1985-10-16
IT8147792A0 (en) 1981-02-13
ES499394A0 (en) 1982-09-01
IE51394B1 (en) 1986-12-24
IT1170717B (en) 1987-06-03
FI810444L (en) 1981-08-16
DE3105307A1 (en) 1981-12-10
IE810282L (en) 1981-08-15
DK147022C (en) 1984-08-27
CZ281275B6 (en) 1996-08-14
NL191792B (en) 1996-04-01
NL960029I1 (en) 1997-02-03
NL960029I2 (en) 1997-04-01
NL191792C (en) 1996-08-02
AU6729881A (en) 1981-08-20
DK147022B (en) 1984-03-19
ES509539A0 (en) 1983-04-01
MY8500757A (en) 1985-12-31
SK403491A3 (en) 1996-02-07
CZ403491A3 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
DK159757C (en) APPLICATION OF NAPHTHALENDER DERIVATIVES FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OR PROPHYLACY OF INFLAMMATION BY TOPIC ADMINISTRATION AND PHARMACEUTICAL PREPARATION FOR TOPICAL USE CONTAINING NAPHTHREEN
ES8701733A1 (en) Redox indicators.
ES8306767A1 (en) Androstene 17 alpha -carbonate 17 beta -carboxylates (and carbothioates)
JPS5366442A (en) Antitumors
SE8100134L (en) THERPENOIDS, PROCEDURES FOR THE PREPARATION OF THESE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FI842815A0 (en) FOERENING OCH KOMPOSITION FOER THERAPEUTIC ELLER DIAGNOSTIC ANVAENDNING OCH THERAPEUTIC BEHANDLINGSMETOD.
HK58385A (en) Androstane carbothioates
GB1521181A (en) Ketolactones and their manufacture
FR2433553A1 (en) RESINS OF UNSATURATED POLYESTERS, NOT INHIBITED BY AIR OXYGEN, THEIR PREPARATION AND THEIR USES
JPS5422331A (en) Preparation of quinones
JPS51143039A (en) An adhesive composition
JPS54125620A (en) Preparation of diazomethane derivative
ES8105250A1 (en) Substituted decalins, their preparation and use.
ES8307803A1 (en) Polycyclic compounds substituted on the A-ring, pharmaceutical compositions containing them, and methods of treating psoriasis with them
ES469513A1 (en) Novel DELTA 4-pregnenes
GB1310741A (en) Anthraquinone dyestuffs
SE7904080L (en) TERMINAL-BIFUNCTIONAL XYLITE DERIVATIVES
JPS5430108A (en) Diyne-type polyprenyl alcohol and hypotensive agent containing the same
DE3469734D1 (en) Biphenylylalkanoic acid derivatives, methods of preparation and pharmaceutical compositions therefrom
JPS5490145A (en) 4-chloromethylsulfonyl-2,6-dinitrohalogenobenzene derivative, and algicide containing the same
JPS5675429A (en) Anti-inflammatory agent containing ethyl piperidylacetylaminobenzoate